M
VINC

Murchinson’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Murchinson’s Portfolio VINC Stock Details VINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,452
Closed -$377K – 121
2021
Q2 		$377K Buy
+1,452
New +$442K 0.14% 65

Other funds holding VINC

SRC
Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Murchinson's VINC Position: Q3 2021 in Review

Murchinson sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q3 2021, closing a stake of 1,452 shares — an estimated $377K sold.

Murchinson first reported a position in VINC in Q2 2021 and held it in 1 quarter. The position peaked at $377K in Q2 2021. 56 funds tracked by Wall St. Rank hold VINC as of Q3 2021.

  • Murchinson reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Murchinson sold 1,452 Vincerx Pharma, Inc. Common Stock shares in Q3 2021, an estimated $377K.
  • Murchinson first reported a position in Vincerx Pharma, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Murchinson's Vincerx Pharma, Inc. Common Stock position peaked at $377K in Q2 2021.
  • 56 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q3 2021.

Based on Murchinson's 13F filing for Q3 2021, filed 15 Nov 2021.